Arbutus Biopharma
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1,574 | $1,339 | $1,726 | $1,532 |
Gross Profit | 1,574 | 1,339 | 1,370 | 1,177 |
EBITDA | -12,169 | -19,352 | -19,406 | -17,476 |
EBIT | -12,502 | -19,688 | -19,762 | -17,831 |
Net Income | -12,532 | -19,717 | -19,796 | -17,875 |
Net Change In Cash | 1,574 | 1,339 | 1,726 | 1,532 |
Free Cash Flow | -10,401 | -20,736 | -14,265 | -19,390 |
Cash | 36,330 | 31,846 | 62,788 | 43,101 |
Basic Shares | 185,608 | 188,997 | 188,041 | 175,625 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $6,171 | $18,141 | $39,019 | $10,988 |
Gross Profit | 6,171 | -55,559 | 37,592 | 9,235 |
EBITDA | -68,403 | -70,986 | -61,859 | -71,637 |
EBIT | -69,783 | -72,390 | -63,286 | -73,390 |
Net Income | -69,920 | -72,849 | -69,456 | -77,351 |
Net Change In Cash | 6,171 | 18,141 | 39,019 | 10,988 |
Cost of Revenue | -78,484 | 57,026 | ||
Free Cash Flow | -64,850 | -86,944 | -35,868 | -68,341 |
Cash | 36,330 | 26,285 | 30,776 | 109,282 |
Basic Shares | 185,608 | 165,960 | 150,939 | 106,242 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.09 |
2024-09-30 | -$0.09 |
2024-06-30 | -$0.11 |
2024-03-31 | -$0.10 |
